A comparative study of the arazyme-based fusion proteins with various ligands for more effective targeting cancer therapy: an in-silico analysis

BACKGROUND AND PURPOSE: Recently, the use of immunotoxins for targeted cancer therapy has been proposed, to find new anticancer drugs with high efficacy on tumor cells with minimal side effects on normal cells. we designed and compared several arazyme (AraA)-based fusion proteins with different liga...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehrab, Rezvan, Sedighian, Hamid, Sotoodehnejadnematalahi, Fattah, Halabian, Raheleh, Fooladi, Abbas Ali Imani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976060/
https://www.ncbi.nlm.nih.gov/pubmed/36873271
http://dx.doi.org/10.4103/1735-5362.367795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976060/
https://www.ncbi.nlm.nih.gov/pubmed/36873271
http://dx.doi.org/10.4103/1735-5362.367795

Ejemplares similares